Skip to main content

Coccidioides immitis Antibodies, IgG and IgM, EIA

CPT 86635(x2)
Synonyms
  • Valley Fever

Test Details

Methodology

EIA

Result Turnaround Time

1 - 2 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

Qualitative detection of antibodies against the fungus Coccidioides to aid in the diagnosis of Coccidioidomycosis (Valley Fever). Specimens positive for Coccidioides antibody by EIA should be confirmed by additional testing (complement fixation and immunodiffusion). Coccidioides live in the dust and soil in some areas of the southwestern United States, Mexico, and South America. In the U.S., Coccidioides live in Arizona, California, Nevada, New Mexico, Texas, and Utah. Many people who are exposed to Coccidioides never develop symptoms. In symptomatic individuals (Valley Fever), symptoms may appear between 1 to 3 weeks after they breathe in fungal spores and usually last for a few weeks to months. Approximately 5% to 10% of people who get Valley Fever will develop serious or long-term problems of the lungs. In approximately 1% of people the infection spreads from the lungs to other parts of the body, such as the central nervous system, skin, or bones and joints. The IgM antibody response (early infection) is measured against the tube precipitin (TP) antigen, and IgG antibody response (late infection) is measured against complement fixation (CF) antigen.

Limitations

Specimens positive for Coccidioides antibody by EIA should be confirmed by additional testing (complement fixation and immunodiffusion). A negative result with both IgM and IgG does not preclude diagnosis of coccidioidomycosis. False-positive due to cross-reactivity has been observed in individuals with other fungal diseases. Diagnosis of coccidioidomycosis should be based on laboratory and clinical findings.

Specimen Requirements

Specimen

Serum

Volume

1 mL

Minimum Volume

0.2 mL (Note: This volume does not allow for repeat testing.)

Container

Gel-barrier tube, serum from gel-barrier tube, serum from red-top tube, or serum transfer tube

Collection Instructions

If tube other than a gel-barrier tube is used, transfer separated serum into a transport tube.

References

Centers for Disease Control and Prevention. Information for Healthcare Professionals about Valley Fever (Coccidioidomycosis). CDC web site: http://www.cdc.gov/fungal/diseases/coccidioidomycosis/health-professionals/cme.html. Accessed September 2021.
Centers for Disease Control and Prevention. Valley Fever (Coccidioidomycosis). CDC web site: http://www.cdc.gov/fungal/diseases/coccidioidomycosis/index.html. Accessed September 2021.
Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Disease Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016 Sep 15;63(6):e112-146.27470238

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
164798 Coccidioides Abs, IgG/IgM, EIA 164773 Coccidioides Ab, IgG, EIA EIA Units 13947-7
164798 Coccidioides Abs, IgG/IgM, EIA 164781 Coccidioides Ab, IgM, EIA EIA Units 13948-5
Order Code164798
Order Code NameCoccidioides Abs, IgG/IgM, EIA
Order Loinc
Result Code164773
Result Code NameCoccidioides Ab, IgG, EIA
UofMEIA Units
Result LOINC13947-7
Order Code164798
Order Code NameCoccidioides Abs, IgG/IgM, EIA
Order Loinc
Result Code164781
Result Code NameCoccidioides Ab, IgM, EIA
UofMEIA Units
Result LOINC13948-5